Pharming Group (PHGUF)
(Delayed Data from OTC)
$0.76 USD
-0.04 (-5.13%)
Updated Aug 2, 2024 10:25 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHGUF 0.76 -0.04(-5.13%)
Will PHGUF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PHGUF based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PHGUF
Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)
Pharming Group N.V. 2024 Q2 - Results - Earnings Call Presentation
Pharming Group NV (PHAR) Q2 2024 Earnings Call Transcript
Pharming Group (PHGUF) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid ...
Pharming Group Sees Strong Revenue Growth in Q2